+29.2%
ABNB vs EMR
+131.1%
-101.9%
-62.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -1.2% | -0.6% | -1.1% |
| 7D | +11.9% | +0.7% | +11.3% | +11.5% |
| 30D | +12.7% | +3.5% | +9.2% | +10.3% |
| 3M | +1.2% | +5.9% | -4.7% | -2.5% |
| 6M | +32.1% | +19.4% | +12.6% | +17.7% |
| YTD | +37.7% | +27.7% | +10.0% | +15.7% |
| 1Y | +55.5% | +30.9% | +24.6% | +28.2% |
| 3Y | +58.2% | +104.2% | -46.0% | -6.2% |
| 5Y | -2.8% | +89.6% | -92.4% | -42.4% |
| All | +29.2% | +131.1% | -101.9% | -17.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling